EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Orally Disintegrating Tablet Formulations in The Treatment of Oral Mucositis

Esra DEMİRTÜRK, Deniz ONAN, Tilbe ÇEVİKELLİ

Cukurova Anestezi ve Cerrahi Bilimler Dergisi · 21.09.2023 · 6 (3) · 406-410

DOI: 10.36516/jocass.1355644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cukurova Anestezi ve Cerrahi Bilimler Dergisi, online erschienen am 21.09.2023. Verfasst von Esra DEMİRTÜRK und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Orally disintegrating tablets (ODT) are widely used dosage forms with high patient compliance, which preferred in the treatment of many diseases currently. In this study we aimed to develop an orally disintegrating tablet formulation can be preferred in the treatment of oral mucositis, which often occurs after chemotherapy during cancer treatment.

Methods

Lidocaine hydrochloride, which is a local anesthetic substance, was used as active pharmaceutical ingredient to obtain ODT formulation for the treatment of oral mucositis. ODTs were prepared by direct compression technique and crospovidone was used as super-dispersant Results: The method developed for lidocaine determination was validated. Characterization of powder mixtures conducted; angle repose was found to be as 25.78°±0.810, flow time was 4.18±0.772 s, compressibility index was 9.591±0.774% and Hausner’s ratio was calculated as 1.106±0.014. The uniformity of weight and content for the ODT formulation was 493.705±3.583 g, 78.89+2.546 mg, respectively. The tablets had a diameter of 12.031 ±0.015 mm while thickness was 4.420 ±0.021 mm. The hardness was calulated as 28.7±1.123 N, while percent friability value was 0.76%. Disintegration time of the tablets were 31.55±0.354 sec., and approximately 90% of the prepared formulation dissolved in around 20 minutes according to dissolution testing.

Conclusions

The prepared formulation was evaluated through powder and tablet controls, it was found to comply with the limits specified in the European Pharmacopoeia. The developed ODT formulation for the treatment of oral mucositis, is planned to be evaluated through in vivo tests to complete the assessment of the formulation.

Zitieren

APA

DEMİRTÜRK, E., ONAN, D., & ÇEVİKELLİ, T. (2023). Evaluation of Orally Disintegrating Tablet Formulations in The Treatment of Oral Mucositis. Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 6(3), 406-410. https://doi.org/10.36516/jocass.1355644

Vancouver

DEMİRTÜRK E, ONAN D, ÇEVİKELLİ T. Evaluation of Orally Disintegrating Tablet Formulations in The Treatment of Oral Mucositis. Cukurova Anestezi ve Cerrahi Bilimler Dergisi. 2023;6(3):406-410. doi:10.36516/jocass.1355644

BibTeX
@article{DEMRTRK2023,
  author = {DEMİRTÜRK, Esra and ONAN, Deniz and ÇEVİKELLİ, Tilbe},
  title = {Evaluation of Orally Disintegrating Tablet Formulations in The Treatment of Oral Mucositis},
  journal = {Cukurova Anestezi ve Cerrahi Bilimler Dergisi},
  year = {2023},
  volume = {6},
  number = {3},
  pages = {406--410},
  doi = {10.36516/jocass.1355644}
}
Kostenlos starten →